We are Gemina Labs, a point-of-care test developer with a proprietary breakthrough chemistry platform. Founded in 2020, the Gemina chemistry platform is an advanced, “universal” bio-sensing toolkit that enables a new generation of diagnostic tests for infectious diseases and beyond. The chemistry platform isn’t just high-performing. It also overcomes many supply chain accuracy bottlenecks in the sector and cuts the development time for prototype tests to weeks. Best of all, the platform empowers “quantitative testing” (not just positive/negative tests) that opens up new applications in personal well-being (stress, fatigue monitoring etc.)